Current Value
$47.211 Year Return
Current Value
$47.211 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IZRL | 0.03% | $116.38M | 0.49% |
IYW | -0.03% | $21.61B | 0.39% |
COM | 0.06% | $207.38M | 0.72% |
ARGT | -0.07% | $1.02B | 0.59% |
IBD | 0.14% | $385.27M | 0.43% |
SLV | -0.14% | $17.19B | 0.5% |
PALL | -0.20% | $515.28M | 0.6% |
BIL | 0.20% | $42.24B | 0.1356% |
CERY | 0.20% | $458.93M | 0.28% |
DBB | 0.26% | $117.01M | 0.77% |
XHLF | -0.29% | $1.73B | 0.03% |
CLSE | 0.35% | $190.30M | 1.44% |
YMAG | -0.36% | $360.94M | 1.12% |
STPZ | -0.44% | $450.47M | 0.2% |
SIVR | -0.47% | $1.98B | 0.3% |
GCC | -0.47% | $139.11M | 0.55% |
FBCG | 0.49% | $4.39B | 0.59% |
IXN | 0.51% | $5.53B | 0.41% |
IBND | -0.51% | $384.31M | 0.5% |
IBDQ | -0.54% | $2.98B | 0.1% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CLIP | -20.47% | $1.51B | 0.07% |
VIXY | -15.40% | $164.54M | 0.85% |
IVOL | -13.11% | $347.03M | 1.02% |
TAIL | -12.29% | $99.63M | 0.59% |
SOYB | -12.18% | $26.67M | 0.22% |
TPMN | -10.94% | $30.70M | 0.65% |
KCCA | -9.67% | $109.43M | 0.87% |
CANE | -8.99% | $10.37M | 0.29% |
WEAT | -6.83% | $117.15M | 0.28% |
ULST | -6.61% | $654.75M | 0.2% |
JMST | -6.41% | $4.06B | 0.18% |
TFLO | -6.22% | $6.82B | 0.15% |
GOAU | -6.08% | $124.14M | 0.6% |
CORN | -5.94% | $44.67M | 0.2% |
DBA | -5.93% | $788.62M | 0.93% |
QFLR | -5.86% | $298.81M | 0.89% |
URNM | -5.70% | $1.75B | 0.75% |
SGOV | -5.66% | $49.21B | 0.09% |
DBMF | -5.41% | $1.17B | 0.85% |
SLVP | -5.35% | $318.59M | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 51.31% | $610.46M | 0.36% |
SPHD | 50.47% | $3.16B | 0.3% |
IHE | 49.39% | $550.45M | 0.39% |
SCHD | 47.87% | $69.17B | 0.06% |
DHS | 47.39% | $1.23B | 0.38% |
XLV | 47.30% | $34.28B | 0.09% |
IYH | 46.70% | $2.73B | 0.39% |
FHLC | 46.59% | $2.44B | 0.084% |
LVHD | 46.35% | $562.24M | 0.27% |
VHT | 46.29% | $15.35B | 0.09% |
IXJ | 46.15% | $3.75B | 0.41% |
FDL | 46.10% | $5.41B | 0.43% |
SPYD | 45.36% | $6.84B | 0.07% |
HDV | 45.06% | $11.02B | 0.08% |
XPH | 45.05% | $147.96M | 0.35% |
SDOG | 44.68% | $1.19B | 0.36% |
RSPH | 44.55% | $729.81M | 0.4% |
CDC | 43.66% | $733.71M | 0.42% |
PEY | 43.53% | $1.10B | 0.53% |
BBH | 43.25% | $330.62M | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PFE | 52.16% | $143.95B | -8.59% | 6.72% |
GILD | 44.42% | $138.71B | +67.46% | 2.80% |
MMM | 42.77% | $82.86B | +51.52% | 1.86% |
JNJ | 42.56% | $374.29B | +6.77% | 3.23% |
AMGN | 42.31% | $159.62B | -4.05% | 3.12% |
DOC | 41.03% | $12.72B | -6.01% | 6.58% |
TMO | 40.89% | $161.48B | -20.14% | 0.38% |
GSK | 40.15% | $77.95B | +0.13% | 4.18% |
FLO | 39.26% | $3.45B | -25.40% | 5.95% |
AVTR | 39.14% | $9.47B | -33.89% | 0.00% |
MKC | 37.94% | $20.55B | +9.57% | 2.30% |
XEL | 37.35% | $38.97B | +28.08% | 3.30% |
PEP | 36.94% | $187.12B | -16.06% | 4.02% |
LNT | 36.76% | $15.61B | +19.58% | 3.22% |
AMRX | 36.74% | $2.62B | +24.00% | 0.00% |
POR | 36.53% | $4.46B | -4.03% | 4.95% |
ELS | 36.39% | $11.78B | -3.08% | 3.23% |
MRK | 36.35% | $206.88B | -34.53% | 3.89% |
NVS | 36.26% | $234.94B | +15.95% | 3.27% |
CSR | 35.81% | $1.02B | -10.27% | 4.97% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
APPF | -0.01% | $8.38B | -6.93% | 0.00% |
AQB | 0.02% | $2.96M | -53.35% | 0.00% |
INTU | 0.02% | $215.82B | +17.24% | 0.52% |
SII | 0.02% | $1.77B | +59.49% | 1.68% |
PENG | 0.04% | $1.07B | -12.55% | 0.00% |
BKSY | -0.05% | $641.59M | +146.00% | 0.00% |
PAY | -0.06% | $3.90B | +61.91% | 0.00% |
LUMN | -0.10% | $4.57B | +327.88% | 0.00% |
FLR | 0.11% | $8.48B | +16.63% | 0.00% |
DLR | -0.11% | $57.98B | +13.48% | 2.84% |
MNOV | -0.11% | $62.29M | -9.29% | 0.00% |
MOD | 0.12% | $5.36B | -5.33% | 0.00% |
SONY | -0.14% | $154.90B | +50.09% | 1.58% |
GENI | -0.14% | $2.34B | +80.70% | 0.00% |
PLCE | 0.15% | $107.07M | -37.44% | 0.00% |
B | -0.16% | $36.49B | +22.66% | 1.89% |
NXE | 0.16% | $3.86B | -4.51% | 0.00% |
GCI | -0.16% | $553.53M | -21.58% | 0.00% |
TARS | -0.19% | $1.70B | +39.82% | 0.00% |
QBTS | -0.19% | $4.99B | +1,352.73% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DXCM | -23.74% | $32.77B | -24.64% | 0.00% |
SPNS | -21.01% | $1.66B | -12.95% | 1.96% |
MNDY | -16.27% | $15.22B | +23.24% | 0.00% |
CRDO | -13.56% | $15.18B | +183.00% | 0.00% |
WRLD | -13.17% | $919.44M | +37.40% | 0.00% |
OR | -12.25% | $4.80B | +61.45% | 0.75% |
KGC | -12.19% | $19.10B | +87.82% | 0.77% |
STRL | -11.79% | $6.96B | +96.28% | 0.00% |
NVDA | -11.76% | $3.84T | +22.58% | 0.03% |
VERX | -11.70% | $5.50B | -2.12% | 0.00% |
FF | -11.32% | $180.47M | -17.76% | 5.80% |
PSN | -11.19% | $7.89B | -8.31% | 0.00% |
BNED | -10.87% | $390.94M | +75.27% | 0.00% |
AXON | -10.76% | $60.30B | +161.18% | 0.00% |
TASK | -10.45% | $1.49B | +21.21% | 0.00% |
RLX | -10.38% | $2.13B | +27.17% | 0.42% |
QNRX | -9.74% | $5.41M | -54.71% | 0.00% |
IAG | -9.62% | $4.27B | +95.01% | 0.00% |
NGD | -9.58% | $3.88B | +132.23% | 0.00% |
EQX | -9.56% | $4.42B | +6.96% | 0.00% |
Yahoo
Prothena slashes 63% of its workforce and axes birtamimab after trial failure, reshaping its pipeline and financial outlook. Shares plunge 53.5% YTD.
Yahoo
Bristol-Myers Squibb Company (NYSE:BMY) is one of the 25 stocks Jim Cramer recently shared insights on. While discussing drug stocks, Cramer mentioned BMY and said: “Of course, some of the rally’s nothing more than the left-behind stocks playing catch up. The drug stocks had a rare day in the sun. I wish I had something […]
Finnhub
BRISTOL-MYERS SQUIBB COMPANY Preliminary Estimated Second Quarter Impact of Acquired In-Process Research and Development and Licensing Income Three months ended...
Yahoo
Bristol Myers' legacy drug sales plunged 20% amid generic erosion and Medicare changes, spotlighting its shift to a newer growth portfolio.
Yahoo
Bristol Myers Squibb (BMY) closed at $47.51 in the latest trading session, marking a +2.64% move from the prior day.
MarketWatch
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
Double maintains 12 strategies that include BMY - Bristol Myers Squibb Co.